Avoid common mistakes on your manuscript.
Esophageal pressure (Peso) has been extensively validated as an estimate of pleural pressure (Ppl). The esophagus is a compliant structure whose rostral–caudal course traverses near the cross-sectional center of the thorax. Thus, the pressure inside the mid-thoracic retro-cardiac esophagus can be utilized to assess the extra-pulmonary intrathoracic pressure. Peso monitoring allows us to estimate trans-pulmonary pressure (PL), defined as the difference between pressure measured in the airway (Paw) and Ppl. PL represents the “true” distending pressure of the lung and is of major importance when considering the risk of ventilator (or patient self)-induced lung injuries [1]. Peso also allows us to assess lung and chest wall elastance independently, thus determining the proportion of the respiratory system distending pressure that is needed to expand the lung and chest wall [2]. In spontaneously breathing patients, Peso measurement also allows quantification of respiratory muscle effort and monitor patient ventilator synchrony [2].
Practically, Peso is measured using a dedicated naso- or orogastric catheter equipped with an air-filled balloon connected to a pressure transducer. Though some Peso catheters include an extra lumen for enteral feeding, insertion of a dedicated Peso catheter adjacent to a feeding tube does not typically interfere with measurement [3]. An intensive care unit (ICU) ventilator with an embedded auxiliary pressure port can ideally be used to simultaneously display the Peso and Paw time curves. As alternatives, dedicated devices or even standard ICU monitors (with proper unit conversion from mmHg to cmH2O) may be used [4]. The esophageal balloon must be carefully placed in the retro-cardiac esophagus, above the gastroesophageal junction (typically 35–40 cm between the nostril or lip and the end of the balloon) and filled with air. Important steps should be completed to ensure Peso measurements reliability [2]. To exclude accidental malpositioning within the airway, inspection of the Peso tracing should confirm it does not appear like the Paw waveform. In passive patients, a gradual, low magnitude rise in Peso during passive insufflation is expected, whereas in actively breathing patients, negative deflection indicative of patient inspiratory effort is observed. Cardiac oscillations in Peso support correct balloon placement. To confirm adequate positioning in the chest, an occlusion test must be performed to verify that changes in Peso amplitude (induced either by a gentle chest compression in passive patients or a patient inspiratory effort) are similar to those measured in Paw during a ventilator circuit occlusion. A ∆Peso/∆Paw ratio of 0.8–1.2 confirms adequate balloon placement. In addition, to obtain reliable absolute Peso values, some groups advocate adjusting the volume of air insufflated in the balloon to achieve the maximum change in Peso between end-inspiration and end-expiration. Since the dynamic and static tidal variations of Peso are very similar, for clinical purposes, the procedure can be performed without occlusion maneuvers at each filling step simply by observing the tidal variation in Peso [4]. Figure 1 illustrates the steps to obtain reliable Peso values.
Peso measurements are often interpreted directly as estimates of Ppl (i.e., Peso = Ppl), but the weight of the mediastinum and the compliances of esophagus and balloon may introduce some imprecision [5]. To overcome this limitation, some authors proposed to estimate PL assessing the amount of applied Paw spent to inflate the lung and to displace the chest wall using the lung to respiratory system elastance ratio (EL/ERS) with PL = Paw × EL/ERS [6]. This elastance ratio-based strategy is nevertheless based on the questionable assumption that Ppl is equal to 0 at functional residual capacity [7]. Important non-clinical studies suggested that directly measured Peso reliably reflects Ppl and thus PL in the dependent lung regions [8], whereas the elastance ratio-based strategy better estimates PL in the non-dependent regions of the lungs.
PL measurements can be used to set positive end-expiratory pressure (PEEP) and/or tidal volume (VT) in patients with acute respiratory distress syndrome (ARDS) with the goal of individualizing lung protective ventilation (Fig. 1). As direct measurements are considered to represent PL in the dependent lung regions, some authors proposed to titrate PEEP for PL at end-expiration (direct measurement) between 0 cmH2O and 2 cmH2O, to avoid lung collapse in these regions. In a preliminary randomized controlled study, such a strategy (where PEEP was set to target expiratory PL between 0 cmH2O and 10 cmH2O according to a FiO2/PL table) led to higher PEEP levels than a classical PEEP/FiO2 table and was associated with better oxygenation and respiratory system compliance [9]. A larger randomized controlled trial however failed in demonstrating better outcome with a similar Peso-guided strategy targeting expiratory PL between 0 cmH2O and 6 cmH2O, compared to a more aggressive PEEP/FiO2 Table [10]. Post hoc analyses suggest that the PL targets used in these trials may have caused over-distension in some patients. The inspiratory PL, a measure of the maximal stress applied to the lungs during inspiration, measured with the direct technique was permitted to reach 20 cmH2O, which is roughly the lung stress experienced at total lung capacity in healthy adults and thus quite high. A post hoc reanalysis of the larger trial suggested that expiratory PL between − 2 cmH2O and 2 cmH2O was associated with decrease in mortality [11]. Titrating PEEP to achieve slightly positive expiratory PL may be particularly beneficial in obese patients [12, 13] in whom Ppl is often high [13]. Once PEEP is set to reach the target end-expiratory PL, VT can be individualized to keep end-inspiratory PL or lung driving pressure (ΔPL, computed as end-inspiratory minus end-expiratory PL within a safe range. Limits of respectively 15 cmH2O and 12 cmH2O can be proposed even if optimal values still must be determined).
Because the elastance ratio-based PL reflects PL in the non-dependent lung regions, where over-distension occurs, this measurement has been suggested to titrate PEEP to the maximal possible value while checking for over-distension (maximal PL value accepted). This strategy allowed to avoid ECMO in 7/14 patients suffering from influenza A H1N1 associated ARDS targeting an elastance ratio-based inspiratory PL of 25 cmH2O [14]. This led to very high PEEP associated with plateau pressure (PPlat) often higher than 30 cmH2O. The stress applied to the lung was however considered as “safe”, as end-inspiratory PL was controlled. Given the preponderance of data suggesting that over-distension can cause clinically significant lung injury, we nevertheless recommend maintaining inspiratory PL well below 20 cmH2O (direct measurements) or 25 cmH2O (elastance ratio-based measurements) even if this hypothesis has not been formally tested. In fact, the safe range for inspiratory PL and for ΔPL warrants clinical studies.
Peso measurements also provide information of major interest during assisted ventilation. It allows us to identify start and end of the inspiratory effort and is thus a sensitive tool to detect patient ventilator asynchronies, particularly ineffective efforts and reverse triggerings, and to optimize ventilator settings to improve synchrony [2]. In addition, Peso monitoring allows precise measurement of inspiratory effort intensity. Peso decrease in amplitude during tidal ventilation is proportional to the intensity of the effort and the maximal pressure generated by the inspiratory muscles during a breath can easily be computed as ∆Peso plus the component needed to expand the chest wall [2]. For physiological studies, the pressure time product and the work of breathing are often used to quantify inspiratory effort more precisely [2]. Bedside effort monitoring using Peso can be used to optimize the amount of support and PEEP during assisted ventilation to keep the effort in an acceptable range that however still has to be determined with further studies [15].
In summary, Peso is a well-validated bedside tool that can help individualize mechanical ventilation to each patient’s unique respiratory system characteristics both during controlled and assisted ventilation. In practice, it can be used to set PEEP and to monitor for occult excessive lung stress. In specific situations, this allows us to safely exceed conventional limits on PEEP and plateau pressure. It also provides help assessing patient ventilator synchrony and respiratory effort to optimize assisted ventilation.
References
Mauri T, Yoshida T, Bellani G, Goligher EC, Carteaux G, Rittayamai N et al (2016) Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives. Intensive Care Med 42(9):1360–1373
Jonkman AH, Telias I, Spinelli E, Akoumianaki E, Piquilloud L (2023) The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspects. Enr Respir Rev 32(168):220186. https://doi.org/10.1183/16000617.0186-2022
Niknam J, Chandra A, Adams AB, Nahum A, Ravenscraft SA, Marini JJ (1994) Effect of a nasogastric tube on esophageal pressure measurement in normal adults. Chest 106(1):137–141
Mojoli F, Iotti GA, Torriglia F, Pozzi M, Volta CA, Bianzina S et al (2016) In vivo calibration of esophageal pressure in the mechanically ventilated patient makes measurements reliable. Crit Care (London, England) 20:98
Hedenstierna G (2012) Esophageal pressure: benefit and limitations. Minerva Anestesiol 78(8):959–966
Gattinoni L, Chiumello D, Carlesso E, Valenza F (2004) Bench-to-bedside review: chest wall elastance in acute lung injury/acute respiratory distress syndrome patients. Crit Care (London, England) 8(5):350–355
Gulati G, Novero A, Loring SH, Talmor D (2013) Pleural pressure and optimal positive end-expiratory pressure based on esophageal pressure versus chest wall elastance: incompatible results*. Crit Care Med 41(8):1951–1957
Yoshida T, Amato MBP, Grieco DL, Chen L, Lima CAS, Roldan R et al (2018) Esophageal manometry and regional transpulmonary pressure in lung injury. Am J Respir Crit Care Med 197(8):1018–1026
Talmor D, Sarge T, Malhotra A, O’Donnell CR, Ritz R, Lisbon A et al (2008) Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 359(20):2095–2104
Beitler JR, Sarge T, Banner-Goodspeed VM, Gong MN, Cook D, Novack V et al (2019) Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-Fio2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 321(9):846–857
Sarge T, Baedorf-Kassis E, Banner-Goodspeed V, Novack V, Loring SH, Gong MN et al (2021) Effect of esophageal pressure-guided positive end-expiratory pressure on survival from acute respiratory distress syndrome: a risk-based and mechanistic reanalysis of the EPVent-2 trial. Am J Respir Crit Care Med 204(10):1153–1163
Chen L, Grieco DL, Beloncle F, Chen GQ, Tiribelli N, Madotto F et al (2022) Partition of respiratory mechanics in patients with acute respiratory distress syndrome and association with outcome: a multicentre clinical study. Intensive Care Med 48(7):888–898
Beloncle FM, Richard JC, Merdji H, Desprez C, Pavlovsky B, Yvin E et al (2023) Advanced respiratory mechanics assessment in mechanically ventilated obese and non-obese patients with or without acute respiratory distress syndrome. Crit Care (London, England) 27(1):343
Grasso S, Terragni P, Birocco A, Urbino R, Del Sorbo L, Filippini C et al (2012) ECMO criteria for influenza A (H1N1)-associated ARDS: role of transpulmonary pressure. Intensive Care Med 38(3):395–403
Widing H, Pellegrini M, Chiodaroli E, Persson P, Hallén K, Perchiazzi G (2024) Positive end-expiratory pressure limits inspiratory effort through modulation of the effort-to-drive ratio: an experimental crossover study. Intensive Care Med Exp 12(1):10
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
LP reports lecture and travel fees from Hamilton Medical, Getinge, Air Liquid medical system, Löwenstein and Fisher and Paykel, all unrelated to this work. LP reports consulting fees from Löwenstein and Getinge, unrelated to this work. JRB reports consulting fees Arrowhead, Biomarck, Global Blood Therapeutics, Hamilton Medical, Mezzion, Sedana Medical, and Stimit within the past year, all unrelated to this work. JRB reports support from the US National Institutes of Health (Grants R01-HL168102, UG3-HL166785) related to this work. FB reports consulting fees from Löwenstein Medical and ALMS, travel fees from ALMS and Draeger and research support from Covidien and Getinge Group, outside this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Piquilloud, L., Beitler, J.R. & Beloncle, F.M. Monitoring esophageal pressure. Intensive Care Med (2024). https://doi.org/10.1007/s00134-024-07401-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00134-024-07401-y